Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

F Baron; M Labopin; A Ruggeri; Jan Cornelissen; E Meijer; H Sengeloev; D Niederwieser; MR De Groot; HC Schouten; N Milpied; D Blaise; BN Savani; E Gluckman; M Mohty; A Nagler

doi:10.1158/1078-0432.ccr-17-3622

Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

F Baron, M Labopin, A Ruggeri, Jan Cornelissen, E Meijer, H Sengeloev, D Niederwieser, MR De Groot, HC Schouten, N Milpied, D Blaise, BN Savani, E Gluckman, M Mohty, A Nagler

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

33 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2794-2803
Number of pages	10
Journal	Clinical Cancer Research
Volume	24
Issue number	12
DOIs	https://doi.org/10.1158/1078-0432.ccr-17-3622
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1158/1078-0432.ccr-17-3622

http://hdl.handle.net/1765/109992

Cite this

Baron, F., Labopin, M., Ruggeri, A., Cornelissen, J., Meijer, E., Sengeloev, H., Niederwieser, D., De Groot, MR., Schouten, HC., Milpied, N., Blaise, D., Savani, BN., Gluckman, E., Mohty, M., & Nagler, A. (2018). Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen. Clinical Cancer Research, 24(12), 2794-2803. https://doi.org/10.1158/1078-0432.ccr-17-3622

@article{6202033acda74f8c850e613d49b2f254,

title = "Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen",

author = "F Baron and M Labopin and A Ruggeri and Jan Cornelissen and E Meijer and H Sengeloev and D Niederwieser and {De Groot}, MR and HC Schouten and N Milpied and D Blaise and BN Savani and E Gluckman and M Mohty and A Nagler",

year = "2018",

doi = "10.1158/1078-0432.ccr-17-3622",

language = "Undefined/Unknown",

volume = "24",

pages = "2794--2803",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "12",

}

Baron, F, Labopin, M, Ruggeri, A, Cornelissen, J, Meijer, E, Sengeloev, H, Niederwieser, D, De Groot, MR, Schouten, HC, Milpied, N, Blaise, D, Savani, BN, Gluckman, E, Mohty, M & Nagler, A 2018, 'Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen', Clinical Cancer Research, vol. 24, no. 12, pp. 2794-2803. https://doi.org/10.1158/1078-0432.ccr-17-3622

TY - JOUR

T1 - Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

AU - Baron, F

AU - Labopin, M

AU - Ruggeri, A

AU - Cornelissen, Jan

AU - Meijer, E

AU - Sengeloev, H

AU - Niederwieser, D

AU - De Groot, MR

AU - Schouten, HC

AU - Milpied, N

AU - Blaise, D

AU - Savani, BN

AU - Gluckman, E

AU - Mohty, M

AU - Nagler, A

PY - 2018

Y1 - 2018

U2 - 10.1158/1078-0432.ccr-17-3622

DO - 10.1158/1078-0432.ccr-17-3622

M3 - Article

SN - 1078-0432

VL - 24

SP - 2794

EP - 2803

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 12

ER -